SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
0.8800 USD   -1.18%
06/23SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
06/10SPECTRUM PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
06/02Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Spectrum Pharma: Q1 Earnings Snapshot

05/12/2022 | 04:08pm EDT

HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $15.4 million in its first quarter.

The Henderson, Nevada-based company said it had a loss of 9 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SPPI at https://www.zacks.com/ap/SPPI

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about SPECTRUM PHARMACEUTICALS, INC.
06/23SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Submission of Ma..
AQ
06/10SPECTRUM PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listi..
AQ
06/02Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
BU
05/26Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predic..
BU
05/26ASCO 2022 : Circulating tumor DNA (ctDNA) in HER2 exon 20 insertion mutations and response..
PU
05/25SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
05/17SPECTRUM PHARMACEUTICALS INC Change in Directors or Principal Officers (form 8-K/A)
AQ
05/17SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financial Statem..
AQ
05/17Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference
BU
05/12TRANSCRIPT : Spectrum Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
More news
Analyst Recommendations on SPECTRUM PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2022 7,30 M - -
Net income 2022 -90,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,74x
Yield 2022 -
Capitalization 155 M 155 M -
Capi. / Sales 2022 21,2x
Capi. / Sales 2023 1,38x
Nbr of Employees 164
Free-Float 90,2%
Chart SPECTRUM PHARMACEUTICALS, INC.
Duration : Period :
Spectrum Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPECTRUM PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 0,88 $
Average target price 5,60 $
Spread / Average Target 536%
EPS Revisions
Managers and Directors
Thomas J. Riga President, CEO, CFO & Director
William L. Ashton Chairman
Francois Lebel Chief Medical Officer & Executive Vice President
Lyndah K. Dreiling Senior Vice President-Clinical Development
Dolatrai M. Vyas Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SPECTRUM PHARMACEUTICALS, INC.-29.88%147
MODERNA, INC.-43.20%54 123
IQVIA HOLDINGS INC.-24.22%38 185
LONZA GROUP AG-35.92%38 059
SEAGEN INC.16.00%31 230
ALNYLAM PHARMACEUTICALS, INC.-13.73%17 102